Dermatology Psoriasis

Table of Contents

RECENT HIGHLIGHTS AND CHANGES
--Recent Highlights and Changes
UPCOMING PATENT EXPIRES BY THERAPY AREA
Psoriasis Pipeline Overview
--% of Projects (By Phase of Development)
--No. of Projects by Phase of Development
--Marketed Products Vs. Pipeline Products
Company Overview - Pipeline Projects
--Company Overview - Pipeline Projects

--Top Companies in late stage Psoriasis Projects
--Allergan Inc
--Abbott Laboratories
--Biovitrum AB
--BioCryst Pharmaceuticals Inc
--Celgene Corporation
--Bristol-Myers Squibb Company
--Centocor, Inc.
--CellGate, Inc
--ChemoCentryx, Inc.
--Cephalon Inc
--Cytochroma Inc.
--CollaGenex Pharmaceuticals Inc
--Hybrigenics
--Genmab A/S
--Ligand Pharmaceuticals Inc
--LEO Pharma A/S
--Manhattan Pharmaceuticals Inc.
--Lupin Ltd
--PharmaMar
--Merrimack Pharmaceuticals, Inc.

--Top Companies in early stage Psoriasis Projects
--AnGes MG, Inc.
--Amgen Inc
--Biofrontera AG
--Bayer Schering Pharma AG
--Can-Fite BioPharma, Ltd.
--BTG plc
--Echo Therapeutics, Inc
--Cephalon Inc
--Genmab A/S
--Eli Lilly & Co
--Kemia, Inc
--Genzyme Corporation
--LEO Pharma A/S
--Laboratorios Almirall, S.A.
--MediQuest Therapeutics, Inc.
--Ligand Pharmaceuticals Inc
--Sosei Group Corporation
--Novartis AG
--Tolerx, Inc.
--Stiefel Laboratories, Inc.

Pipeline Revenue
--Pipeline Revenue
Full Pipeline View
--Pre Clinical Pipeline View
--Phase I Pipeline View
--Phase II Pipeline View
--Phase III Pipeline View
--Pending Approval Pipeline View
--Approved Pipeline View
--Post Marketing Pipeline View
--On the Market Pipeline View
--Discovery/Development Pipeline View